Results 151 to 160 of about 75,323 (218)

Formulation and Physicochemical Characterization of Capecitabine-Loaded Cubosomes for Enhanced Drug Delivery System. [PDF]

Drug Des Devel Ther
Salawi A.
europepmc   +1 more source

Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors. [PDF]

Oncologist
Torrisi R, Giugliano F, Giordano L, Saltalamacchia G, Jacobs F, Carnevale Schianca A, Milano M, Bianco N, Sangalli CA, De Sanctis R, Masci G, Curigliano G, Santoro A, Munzone E.   +13 more
europepmc   +1 more source

Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study. [PDF]

Br J Cancer
He SQ, Huang Y, Zhao ZY, Wen SQ, Lv SH, Wang L, Bei WX, Xiang YQ, Liu GY.   +8 more
europepmc   +1 more source

Nudge-based patient education by pharmacists to promote self-care behaviors for preventing and mitigating chemotherapy-induced skin toxicity: rationale, design, and study protocol of the PHARM-NUDGE trial. [PDF]

J Pharm Health Care Sci
Ito Y, Suzuki K, Hatori M, Yagi T, Miyamoto Y, Sato H, Watabe S, Shibata N, Otsuka Y, Yagi T, Kawakami J.   +10 more
europepmc   +1 more source

Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion. [PDF]

Breast Cancer Res Treat
Lee TH, Lee H, Jang JY, Park W, Cho WK, Cho EY, Ahn JS, Park YH, Nam SJ, Kim SW, Lee JE, Kim H.   +11 more
europepmc   +1 more source

HER2陽性転移・再発乳癌に対し，Trastuzumab(H)＋ Pertuzumab(P)＋XC(Capecitabine＋Cyclophosphamide） を投与した２例 [PDF]

, 2017
二宮, 凛, 二宮, 淳, 佐々木, 勝海, 内田, 惠博, 大矢, 真里子, 小島, 誠人, 小川, 利久, 林原, 紀明, 石綱, 一央, 辻, 英一   +9 more
core  

Mammary metaplastic squamous cell carcinoma: a case report. [PDF]

J Med Case Rep
Tianqing Y, Guoliang Z, Shuqi L, Muyi Z, Yuanqi Z, Weiqiang L, Rong Z, Jiansen Y.   +7 more
europepmc   +1 more source

Unraveling the role of 3-mercaptopyruvate sulfurtransferase-derived hydrogen sulfide in triple-negative breast cancer chemoresistance. [PDF]

Front Pharmacol
Hakim S, Habashy DA, Ascenção K, Youness RA, Bourquin C, Szabo C, Gad MZ, Abdelkader RM.   +7 more
europepmc   +1 more source

Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy. [PDF]

Front Oncol
Godoy-Ortíz A, Lendínez-Sánchez G, Zalabardo M, Pascual J, López-Pascual A, Cantero A, Ribelles N, Iglesias M, Villar E, Pajares B, Díaz-Redondo T, Domínguez-Recio ME, Carabantes F, Bermejo MJ, Rueda-Domínguez A, Alba E, Sánchez-Muñoz A.   +16 more
europepmc   +1 more source

Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study. [PDF]

Drug Des Devel Ther
Xiang J, Sun P, Liu Z, Zhang Q, Song L, Liu J.   +5 more
europepmc   +1 more source